Participants were aged 1885 years with symptoms for at least 3 months, a modified MS of 5-9, MES of at least 2, and Robarts Histopathology Index score of at least 10, and the primary outcome was change in histopathology score from baseline to week 12, which showed a mean reduction of 6.4 points with 22.9% achieving remission at 12 weeks and 31.4% at 52 weeks
Key risks of combining berberine and semaglutide include: Low blood sugar (hypoglycemia), particularly if you also use insulin or sulfonylureas Worsening GI symptoms such as nausea, cramping, bloating, diarrhea, or constipation Drug interactions from berberines effects on liver enzymes, which can change levels of other prescriptions These risks are the reason a clinician should review your full situation before you start the combo
Dopo 4 settimane, aumentare il dosaggio a 0,5 mg una volta alla settimana
In all above scenarios, once-weekly semaglutide 0.5 mg and 1 mg remained dominant over sitagliptin with more QALYs and lower costs
Lonardo, A., Nascimbeni, F., Mantovani, A